News
EU and China cooperation dialogue for STI
On 9 April, the fourth Innovation Cooperation Dialogue, co-chaired by the European Commissioner for Research, Science and Innovation, Carlos Moedas and the Chinese Minister of Science & Technology, Wang Zhigang, took place in Brussels, in margins of the EU-China Summit.
Stryker joins the Avicenna Alliance
The Avicenna Alliance is proud to announce the newest addition to its list of members: Stryker. Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.
FEops HEARTguideTM receives CE mark
The Avicenna Alliance Secretariat is proud to announce that one of its members, FEops, has received the ‘CE’ mark for its FEops HEARTguideTM. The CE marking proves that a product has been assessed by the relevant notified bodies and meets all the European requirements on safety, health and environmental protection enabling the manufacturer to sell his product in the European Economic Area.
Avicenna Alliance at the 2019 BMES Conference – Frontiers in medical devices
The Avicenna Alliance returned to the BMES Conference this year providing an opportunity to catch up with current members and to engage with potential new members.
Avicenna Alliance at Capitol Hill for meetings at the US Congress
The Avicenna Alliance returns from a contact programme to the US Senate and House of Representatives with resounding success and clear next steps for furthering in silico medicine through policy. The delegation, consisting of Avicenna Alliance members, 4 representatives of the US Food and Drug Administration (FDA) and 2 Observer Representatives of the European Commission met with the Office of Senator Ben Cardin and of Representative Dutch Ruppersberger.
VPH institute – Drives In Silico technology to the clinic
The VPH institute is an open community of scientists and clinicians focused on the development and uptake of computer modeling & simulation in healthcare. It is not just a scientific society as it involves a wide range of external stakeholders, such as industry and policy representatives, and federal agency employees that collaborate with the VPH Institute to advance the field of predictive medicine and make sure that in silico technology can make it to the clinic.
